Old Web
English
Sign In
Acemap
>
authorDetail
>
Helene Grassin
Helene Grassin
Pancreatic cancer
Oncology
Gemcitabine
Oxaliplatin
Internal medicine
2
Papers
173
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy.
2016
Journal of Clinical Oncology
Sharlene Gill
Yoo-Joung Ko
C. Cripps
Annie Beaudoin
Sukhbinder Dhesy-Thind
Muhammad Zulfiqar
Pawel Zalewski
Thuan Do
Pablo Cano
Wendy Yin Han Lam
Scot Dowden
Helene Grassin
John H. Stewart
Malcolm A. Moore
Show All
Source
Cite
Save
Citations (136)
PANCREOX: A randomized phase 3 study of 5FU/LV with or without oxaliplatin for second-line advanced pancreatic cancer (APC) in patients (pts) who have received gemcitabine (GEM)-based chemotherapy (CT).
2014
Journal of Clinical Oncology
Sharlene Gill
Yoo Joung Ko
M. Christine Cripps
Annie Beaudoin
Sukhbinder Dhesy-Thind
Muhammad Zulfiqar
Pawel Zalewski
Thuan Do
Pablo Cano
Wendy Lam
Scot Dowden
Helene Grassin
John H. Stewart
Malcolm J. Moore
Show All
Source
Cite
Save
Citations (37)
1